Right, years not hours!

My goal here is quite simple. I want to accurately model the BETonMACE trial. Once we get the 250th MACE event this should be even easier to do.

I'm writing a research report on RVX and the science to me is well understood at this point. While the pathways and mechanism of action are clear to me and my firm, it's not nearly as clear to the rest of the community and other investors. What RVX is doing is on the cutting edge of our understanding of the human body. Even the company is still trying to wrap its head around the implications, of which there are many like a complete revamping of how the world understands inflammatory diseases and what an inflammatory disease is. Thus by adding in hard data from the trial, we can further support our argument and case to show that there's real promise and real science at work. 

Hope that helps,
Pomp